ASBP vs REGN: Which Stock is Better?

Side-by-side comparison of Aspire Biopharma Holdings Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ASBP

Aspire Biopharma Holdings Inc

$5.41

REGN

Regeneron Pharmaceuticals Inc

$638.88

Key Metrics Comparison

MetricASBPREGNWinner
Market Cap$7.01M$66.98BREGN
P/E RatioN/A15.60REGN
EPS (TTM)$N/A$40.95REGN
Revenue Growth0.0%0.2%REGN
Gross Margin16.3%43.9%REGN

Analyze ASBP

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ASBP or REGN a better investment?

Comparing ASBP and REGN: Aspire Biopharma Holdings Inc has a market cap of $7.01M while Regeneron Pharmaceuticals Inc has $66.98B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ASBP and REGN?

ASBP (Aspire Biopharma Holdings Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ASBP or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ASBP or REGN?

REGN has higher revenue growth at 0.2% vs 0.0% for ASBP.

Which company is more profitable: ASBP or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 43.9% compared to 16.3% for ASBP.

Which is the larger company: ASBP or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $66.98B compared to $7.01M for ASBP.

Should I buy ASBP or REGN in 2026?

Both ASBP and REGN have investment merit. ASBP trades at $5.41 while REGN trades at $638.88. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ASBP and REGN stock?

Key differences: Market Cap ($7.01M vs $66.98B), P/E Ratio (N/A vs 15.6x), Revenue Growth (0.0% vs 0.2%), Gross Margin (16.3% vs 43.9%).

Popular Stock Comparisons